Mohamed Eshmawey

Dr. Mohamed Eshmawey

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Claudio L.A. BassettiClaudio L.A. Bassetti
Claudio L.A. Bassetti
Mirjam R HeldnerMirjam R Heldner
Mirjam R Heldner
KAKristina Adorjan
Kristina Adorjan
EAEmiliano Albanese
Emiliano Albanese
GAGilles Allali
Gilles Allali
LRLuca Remonda
Luca Remonda
The brain and its health are essential for our (physical mental, social, and spiritual) wellbeing, for being able to realize our potential as individuals, and also for a fair, well-functioning, and productive society. However, today the world is facing a healthcare crisis related to the very high (and increasing) burden of brain disorders. As a response to this crisis, the “Swiss Brain Health Plan” (SBHP) was conceptualized in the context of other initiatives launched to value, promote, and protect brain health over the entire life course. In the first section of this position paper, the following fundamental considerations of the SBHP are discussed: (1) the high (and increasing) burden of brain disorders in terms of prevalence (>50% of the population suffers from a brain disorder), disability, mortality, and costs; (2) the prevention of brain disorders; (3) the operational definition of brain health; (4) determinants of brain health; (5) international initiatives to promote brain (including mental) health including the World Health Organization (WHO) intersectorial global action plan on epilepsy and other neurological disorders (NDs) (IGAP) and the WHO comprehensive mental health action plan. In the second section of the paper, the five strategic objectives of the SBHP, which has the vision of promoting brain health for all across the entire life course, are presented: (1) to raise awareness; (2) strengthen cross-disciplinary and interprofessional training/educational programs for healthcare professionals; (3) foster research on brain health determinants and individualized prevention of brain disorders; (4) prioritize a holistic (non-disease-specific), integrated, person-centered public health approach to promote brain health and prevent brain disorders through collaborations across scientific, health care, commercial, societal and governmental stakeholders and insurance providers; (5) support, empower, and engage patients, caregivers, and patient organizations, and reduce the stigma and discrimination related to brain disorders. In the third section of the paper, the first (2024) steps in the implementation of the SHBP, which will be officially launched in Zurich on 22 November 2023, are presented: (1) a definition of the overall organization, governance, specific targets, and action areas of the SBHP; (2) the patronage and/or co-organization of events on such specific topics as brain research (Lausanne), dementia (Geneva), stroke (Basel), neurohumanities (Bellinzona), sleep (Lugano), and psychiatry (Zurich); (3) the conduction of a new study on the global burden of brain disorders in Switzerland; (4) the launching of an international Certificate of Advanced Studies (CAS) on Brain Health at the University of Bern. In the fourth section of the paper, there is a concise executive summary of the SBHP.

1 January 2019 in Dementia and Geriatric Cognitive Disorders
Verified
Journal Article
Closed access
PDF file
MEMohamed Eshmawey
Mohamed Eshmawey
SASönke Arlt
Sönke Arlt
CLChristine Ledschbor-Frahnert
Christine Ledschbor-Frahnert
UGUlf Guenther
Ulf Guenther
PJPopp Julius
Popp Julius
Background: Delirium is common in old patients who undergo cardiac surgery, and it is associated with adverse outcomes. The genesis of delirium is thought to be multi-factorial, but it is still not well understood. Symptoms of depression and elevated cortisol level have been described in some previous studies as factors associated with delirium, suggesting a shared pathophysiology. Aims: The objective of the present study was to determine whether preoperative depression symptoms and increased cortisol level represent risk factors for delirium after cardiac surgery. Methods: We performed a prospective cohort study in 183 patients aged >50 years undergoing elective cardiac surgery. The Geriatric Depression Scale (GDS) was used to assess patients for depressive symptoms before surgery. Preoperative plasma cortisol levels were available in 145 participants. Delirium was diagnosed using the Confusion Assessment Method for Intensive Care Unit (CAM-ICU) during the first 7 days after surgery. Spearman correlation was used for correlations between GDS, Mini-Mental State Examination (MMSE), Charlson comorbidity index, and age. Binary logistic regression was used to determine whether GDS and cortisol levels predict postoperative delirium. Results: Delirium occurred in 60 patients out of 183 (32.8%) included and lasted 2.3 days (SD 1.36). GDS was correlated with age (p = 0.001) and comorbidity index (p = 0.003) and inversely correlated with MMSE score (p < 0.001). Higher preoperative GDS scores were associated with incidence of delirium in the postoperative period (p = 0.002). The association was significant after controlling for age, MMSE score, history of stroke, and Charlson comorbidity index (p = 0.045). Preoperative cortisol level was not associated with the development of postoperative delirium. Conclusion: Our results suggest that a higher preoperative depression score is associated with an increased risk of postoperative delirium. On the other hand, preoperative plasma cortisol level does not seem to be a predictor of delirium after surgery. Further studies are needed to determine the potential of preoperative depression treatment to prevent postoperative delirium.

18 January 2022 in Neurodegenerative Diseases
Verified
Journal Article
Open access
PDF file
MEMohamed Eshmawey
Mohamed Eshmawey
Background: Many factors affect sexuality in the elderly such as dementia which is a common cause of inappropriate sexual behaviors. These behavioral disturbances are distressing, disruptive, and impair the care of the patient. Summary: The onset of dementia does not erase sexuality. Sexual expression can be an important aspect of well-being for older adults with dementia. This study gives a general overview about the relationship between sexuality and cognitive impairment. It starts with a general discussion of sexual aspects in the elderly. This is followed by research studies in this field including effects of dementia on sexual life, sexuality issues related to cognitive decline, inappropriate sexual behaviors in dementia patients, and sexuality in healthcare institutions. We discuss also ethical aspects in relation with sexuality and dementia. Finally, we show different approaches to treat inappropriate sexual behaviors. Key Messages: The discussion of sexuality in dementia raises many medical and ethical concerns. Inappropriate sexual behaviors are estimated to occur in about 7%–25% of demented patients. The question is how to address such a delicate subject and discuss it in an easy way without making the patient feel humiliated or mistreated. This narrative review reveals sexual problems and difficult questions encountered in daily practice with patients suffering from cognitive impairment.

MEMohamed Eshmawey
Mohamed Eshmawey
Background: Delirium and dementia are highly interrelated. Delirium superimposed on dementia can alter the course of an underlying cognitive impairment, with dramatic worsening of the trajectory of cognitive decline, resulting in more rapid progression of functional losses. This review seeks to identify challenges in the recognition and management of delirium superimposed on dementia and highlight strategies to improve patient care. It also aims to examine its pathophysiology, risk factors, diagnosis and clinical outcomes. Methods: This narrative review discusses the current knowledge on close interaction between delirium and dementia. We searched the following databases: PubMed, Google Scholar, Web of Science, and AgeLine. A comprehensive literature search was conducted for studies published between 1970 and 2026. Results: Dementia is a known risk factor for delirium. The literature suggests that cerebral vulnerability in patients with dementia may predispose them to the development of delirium. This review gives a general overview of delirium superimposed on dementia. It starts with a general discussion of the nature of the interrelationship between delirium and dementia. This is followed by research studies in this field, including pathophysiological relations between delirium and dementia, and the effects of delirium on dementia progression. Finally, we show different methods to manage delirium in patients with dementia. The review identifies the following key findings: (1) the coexistence of dementia and delirium presents significant diagnostic challenge because of overlapping symptoms; (2) delirium superimposed on dementia is associated with poorer clinical outcomes than either condition alone, including accelerated cognitive and functional decline; (3) prevention remains the most effective management strategy; and (4) multicomponent non-pharmacological interventions, carried out by a multidisciplinary team, have demonstrated benefits in reducing delirium incidence. Conclusions: Delirium superimposed on dementia is frequently under-recognized. Early diagnosis and management of delirium superimposed on dementia can be challenging. More effort is needed to better standardize and optimize symptom assessment. Multicomponent preventive measures should be applied to decrease the risk of this condition. The aim of the treatment is to identify and treat the underlying cause. It is essential to improve caregivers’ knowledge about this syndrome to improve healthcare quality.

26 October 2025 in Journal of General and Family Medicine
Verified
Journal Article
Open access
MEMohamed Eshmawey
Mohamed Eshmawey
SKSonja Kagerer
Sonja Kagerer
FRFederica Ribaldi
Federica Ribaldi
AFAïda B. Fall
Aïda B. Fall
PUPaul Gerson Unschuld
Paul Gerson Unschuld
Background: Subjective cognitive decline (SCD) is characterized by the perception of cognitive dysfunction, and it could be one of the early signs of dementia. While SCD is a common phenomenon in old persons, little is known about how it affects interpersonal relationships. Methods: We conducted a cross‐sectional study involving 16 patients with SCD and 39 volunteers recruited from the COSCODE study. The Hazan and Shafer questionnaires were used to assess patients' attachment styles. The Experience in Close Relationships Scale was used to assess individual differences in attachment‐related anxiety and attachment‐related avoidance. A Wilcoxon rank‐sum test was performed to test for differences between groups, and p ‐values were Bonferroni‐corrected. Results: SCD is associated with lower disorganized attachment scores ( p = 0.01). SCD was not associated with experience in close relationships. Conclusion: Coping with progressive cognitive decline is a difficult mission. The results of our study on persons with SCD help us to better understand changes in couple relationships before the onset of dementia.

UNUmberto Nencha
Umberto Nencha
MEMohamed Eshmawey
Mohamed Eshmawey
DADaniele Altomare
Daniele Altomare
BMBoccardi Marina
Boccardi Marina
LSLeonardo Sacco
Leonardo Sacco
SKSonja Kagerer
Sonja Kagerer
Alzheimer’s disease has recently been redefined as a complex clinical–biological entity by the International Working Group (IWG), and while the cognitive symptoms associated with the disease progression have been thoroughly investigated, subtle behavioral changes that precede functional decline have been less systematically explored. Mild Behavioral Impairment has recently emerged and been operationalized with a dedicated checklist (MBI-C) to identify individuals presenting later-life persistent behavioral changes that might represent the first clinical signs related to an underlying neurodegenerative process. Here, we review current evidence supporting MBI as a promising clinical marker along the Alzheimer’s disease (AD) continuum since its preclinical stages, and we call for further research to investigate the potential added clinical value of a more structured, systematic assessment of behavioral changes in individuals at risk of progression. We outline that a structured MBI assessment could therefore be integrated first into future research diagnostic frameworks and, once validated in real-world settings, into routine clinical workups. Assessing MBI could then become a cost-effective, non-invasive tool aiding in distinguishing early neurodegenerative from primarily psychiatric disorders.